Braskem (BAK) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
The heavy selling pressure might have exhausted for Braskem (BAK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
PBR and IG4 formalize joint control of Braskem, establishing a new governance structure aimed at strengthening the company's future.
| Chemicals Industry | Materials Sector | Roberto Prisco Paraíso Ramos CEO | XDUS Exchange | US1055321053 ISIN |
| BR Country | 8,233 Employees | 12 May 2022 Last Dividend | 16 May 2005 Last Split | - IPO Date |
Braskem S.A., founded in 1972 and headquartered in São Paulo, Brazil, is a leading company in the production and sale of thermoplastic resins. Initially named Copene Petroquímica do Nordeste S.A., the company underwent a name change to Braskem S.A. in 2002. As a subsidiary of Novonor S.A., Braskem has established a significant presence in the chemicals and petrochemicals sector, playing a vital role in the production of a wide array of products ranging from olefins and intermediates to polyethylene and specialty chemicals. Its expansive portfolio also extends to the provision of utilities and the manufacture of chemical precursors for various industrial processes, underscoring its diversified operations and comprehensive market reach.